These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 34057685)

  • 1. Cross-talk between non-coding RNAs and PI3K/AKT/mTOR pathway in colorectal cancer.
    Moafian Z; Maghrouni A; Soltani A; Hashemy SI
    Mol Biol Rep; 2021 May; 48(5):4797-4811. PubMed ID: 34057685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOTAIR/miR-326/FUT6 axis facilitates colorectal cancer progression through regulating fucosylation of CD44 via PI3K/AKT/mTOR pathway.
    Pan S; Liu Y; Liu Q; Xiao Y; Liu B; Ren X; Qi X; Zhou H; Zeng C; Jia L
    Biochim Biophys Acta Mol Cell Res; 2019 May; 1866(5):750-760. PubMed ID: 30742932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression.
    Li Y; Zeng C; Hu J; Pan Y; Shan Y; Liu B; Jia L
    J Hematol Oncol; 2018 Jul; 11(1):89. PubMed ID: 29970122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PI3K/Akt/mTOR axis in colorectal cancer: Oncogenic alterations, non-coding RNAs, therapeutic opportunities, and the emerging role of nanoparticles.
    Sanaei MJ; Baghery Saghchy Khorasani A; Pourbagheri-Sigaroodi A; Shahrokh S; Zali MR; Bashash D
    J Cell Physiol; 2022 Mar; 237(3):1720-1752. PubMed ID: 34897682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway.
    Liu B; Pan S; Xiao Y; Liu Q; Xu J; Jia L
    J Exp Clin Cancer Res; 2018 Dec; 37(1):316. PubMed ID: 30547804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
    Yin F; Huang X; Xuan Y
    Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging role of noncoding RNAs in the PI3K/AKT/mTOR signalling pathway in breast cancer.
    Abu-Alghayth MH; Khan FR; Belali TM; Abalkhail A; Alshaghdali K; Nassar SA; Almoammar NE; Almasoudi HH; Hessien KBG; Aldossari MS; Binshaya AS
    Pathol Res Pract; 2024 Mar; 255():155180. PubMed ID: 38330621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SP1-induced lncRNA TINCR overexpression contributes to colorectal cancer progression by sponging miR-7-5p.
    Yu S; Wang D; Shao Y; Zhang T; Xie H; Jiang X; Deng Q; Jiao Y; Yang J; Cai C; Sun L
    Aging (Albany NY); 2019 Mar; 11(5):1389-1403. PubMed ID: 30853664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment.
    Leiphrakpam PD; Are C
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabolism.
    Ellis BC; Graham LD; Molloy PL
    Biochim Biophys Acta; 2014 Feb; 1843(2):372-86. PubMed ID: 24184209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Non-Coding RNAs (lncRNAs) as Regulators of the PI3K/AKT/mTOR Pathway in Gastric Carcinoma.
    Riquelme I; Pérez-Moreno P; Mora-Lagos B; Ili C; Brebi P; Roa JC
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway.
    Li Y; Peng F; Tan X; Wang J; Xu Y
    Genes Genomics; 2021 Oct; 43(10):1189-1198. PubMed ID: 34417976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal MALAT1 sponges miR-26a/26b to promote the invasion and metastasis of colorectal cancer via FUT4 enhanced fucosylation and PI3K/Akt pathway.
    Xu J; Xiao Y; Liu B; Pan S; Liu Q; Shan Y; Li S; Qi Y; Huang Y; Jia L
    J Exp Clin Cancer Res; 2020 Mar; 39(1):54. PubMed ID: 32209115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PI3K/ Akt/ mTOR Pathway as a Therapeutic Target for Colorectal Cancer: A Review of Preclinical and Clinical Evidence.
    Narayanankutty A
    Curr Drug Targets; 2019; 20(12):1217-1226. PubMed ID: 31215384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B7-H4 facilitates proliferation and metastasis of colorectal carcinoma cell through PI3K/Akt/mTOR signaling pathway.
    Li C; Zhan Y; Ma X; Fang H; Gai X
    Clin Exp Med; 2020 Feb; 20(1):79-86. PubMed ID: 31664539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA SNHG6 inhibits cell proliferation and metastasis by targeting ETS1 via the PI3K/AKT/mTOR pathway in colorectal cancer.
    Meng S; Jian Z; Yan X; Li J; Zhang R
    Mol Med Rep; 2019 Sep; 20(3):2541-2548. PubMed ID: 31322251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To Investigate the Occurrence and Development of Colorectal Cancer Based on the PI3K/AKT/mTOR Signaling Pathway.
    Zhong J; Ding S; Zhang X; Di W; Wang X; Zhang H; Chen Y; Zhang Y; Hu Y
    Front Biosci (Landmark Ed); 2023 Feb; 28(2):37. PubMed ID: 36866550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Glut1 gene silencing on proliferation, differentiation, and apoptosis of colorectal cancer cells by targeting the TGF-β/PI3K-AKT-mTOR signaling pathway.
    Wu XL; Wang LK; Yang DD; Qu M; Yang YJ; Guo F; Han L; Xue J
    J Cell Biochem; 2018 Feb; 119(2):2356-2367. PubMed ID: 28884839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.
    Song L; Zhou Z; Gan Y; Li P; Xu Y; Zhang Z; Luo F; Xu J; Zhou Q; Dai F
    J Cell Biochem; 2019 Jun; 120(6):9656-9666. PubMed ID: 30548308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.